Abstract
Lentiviral vectors have become very useful tools for transgene delivery. Based on their ability to transduce both dividing and nondividing cells and to produce long-term transgene expression, lentiviruses have found numerous applications in the biomedical sciences, including developmental neuroscience. This protocol describes how to prepare lentiviral vectors by calcium phosphate transfection and to concentrate viral particles by ultracentrifugation. Functional vector titers can then be determined by methods such as fluorescence-activated cell sorting or immunostaining. Effective titers in the range of 108–109 infectious units/ml can be routinely obtained using these protocols. Finally, we describe the infection of primary neuronal cultures with lentiviral vectors resulting in 85–90 % cell transduction using appropriate multiplicities of infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lewis P, Hensel M, Emerman M (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 11(8):3053–3058
Weinberg JB, Matthews TJ, Cullen BR, Malim MH (1991) Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med 174(6):1477–1482
Matrai J, Chuah MK, VandenDriessche T (2010) Recent advances in lentiviral vector development and applications. Mol Ther 18(3):477–490
Delenda C (2004) Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 6(Suppl 1):S125–S138
Zaiss AK, Son S, Chang LJ (2002) RNA 3′ readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy. J Virol 76(14):7209–7219
Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72(12):9873–9880
Frecha C, Szecsi J, Cosset FL, Verhoeyen E (2008) Strategies for targeting lentiviral vectors. Curr Gene Ther 8(6):449–460
Tiscornia G, Singer O, Verma IM (2006) Production and purification of lentiviral vectors. Nat Protoc 1(1):241–245
Zimmermann K, Scheibe O, Kocourek A, Muelich J, Jurkiewicz E, Pfeifer A (2011) Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration. BMC Biotechnol 11(1):55
Ichim CV, Wells RA (2011) Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation. J Transl Med 9:137
Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R (2006) Comparison of lentiviral vector titration methods. BMC Biotechnol 6:34
Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, Kohn DB (2004) Factors influencing the titer and infectivity of lentiviral vectors. Hum Gene Ther 15(10):976–988
Scherr M, Battmer K, Blomer U, Ganser A, Grez M (2001) Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 31(3):520, 522, 524, passim
Ricks DM, Kutner R, Zhang XY, Welsh DA, Reiser J (2008) Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 17(3):441–450
Radcliffe PA, Sion CJ, Wilkes FJ, Custard EJ, Beard GL, Kingsman SM, Mitrophanous KA (2008) Analysis of factor VIII mediated suppression of lentiviral vector titres. Gene Ther 15(4):289–297
Wang W, Qu Q, Smith FI, Kilpatrick DL (2005) Self-inactivating lentiviruses: versatile vectors for quantitative transduction of cerebellar granule neurons and their progenitors. J Neurosci Methods 149(2):144–153
Lizee G, Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA, Topalian SL (2003) Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 14(6):497–507
Kutner RH, Zhang XY, Reiser J (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4(4):495–505
Wang W, Stock RE, Gronostajski RM, Wong YW, Schachner M, Kilpatrick DL (2004) A role for nuclear factor I in the intrinsic control of cerebellar granule neuron gene expression. J Biol Chem 279(51):53491–53497
Wang W, Mullikin-Kilpatrick D, Crandall JE, Gronostajski RM, Litwack ED, Kilpatrick DL (2007) Nuclear factor I coordinates multiple phases of cerebellar granule cell development via regulation of cell adhesion molecules. J Neurosci 27(23):6115–6127
Kumar P, Woon-Khiong C (2011) Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications. Curr Gene Ther 11(2):144–153
Osten P, Dittgen T, Licznerski P (2006) Lentivirus-based genetic manipulations in neurons in vivo. In: Kittler JT, Moss SJ, editors. The Dynamic Synapse: Molecular Methods in Ionotropic Receptor Biology. Boca Raton (FL): CRC Press; 2006. Chapter 13.
Wang W, Shin Y, Shi M, Kilpatrick DL (2011) Temporal control of a dendritogenesis-linked gene via REST-dependent regulation of nuclear factor I occupancy. Mol Biol Cell 22(6):868–879
Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73(4):2886–2892
VandenDriessche T, Thorrez L, Naldini L, Follenzi A, Moons L, Berneman Z, Collen D, Chuah MK (2002) Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100(3):813–822
Jordan M, Wurm F (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33(2):136–143
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ding, B., Kilpatrick, D.L. (2013). Lentiviral Vector Production, Titration, and Transduction of Primary Neurons. In: Zhou, R., Mei, L. (eds) Neural Development. Methods in Molecular Biology, vol 1018. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-444-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-444-9_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-443-2
Online ISBN: 978-1-62703-444-9
eBook Packages: Springer Protocols